Observational studyBMC microbiology2026
Post-pandemic resurgence and co-detectiondynamics of respiratory pathogens revealed by syndromic multiplex PCR.
Observational study in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute respiratory tract infections are a major cause of morbidity and healthcare burden worldwide. Because many respiratory pathogens such as influenza viruses, Respiratory Syncytial Virus (RSV), Rhinovirus/Enterovirus, and SARS-CoV-2 present with overlapping clinical features, rapid and accurate etiological diagnosis is essential for effective patient management. Syndromic multiplex PCR panels, particularly the BioFire FilmArray Respiratory Panel 2.1 Plus (RP2.1 Plus), enable the simultaneous detection of a broad range of viral and bacterial pathogens, facilitating the identification of both mono- and co-infections.
objectivesThis study aimed to investigate the distribution of respiratory pathogens, co-detectionpatterns, seasonal variation, and sequential infections in patients with suspected respiratory tract infections using BioFire RP2.1 Plus in a tertiary-care hospital in Türkiye.
methodsIn this retrospective observational study, 360 respiratory samples obtained from 314 patients between March 2024 and March 2025 were analysed. All samples were tested using the BioFire FilmArray RP2.1 Plus system. Pathogen frequencies, mono- and co-detectionrates, demographic associations, seasonal distribution, and correlations between circulating pathogens were evaluated using appropriate statistical methods.
resultsAt least one respiratory pathogen was detected in 55.8% (201/360) of samples. A total of 253 pathogens were identified. The most frequent pathogen was Rhinovirus/Enterovirus (38.7%), followed by influenza A (12.3%), adenovirus (10.7%), SARS-CoV-2 (7.9%), RSV (6.3%), and Mycoplasma pneumoniae (4.3%). Co-detections were identified in 20.4% of positive samples, with binary co-infections being the most common. Rhinovirus/Enterovirus was the dominant pathogen in all co-detectioncategories. Women and children had significantly higher positivity rates than men and adults, respectively. Marked seasonal variation was observed: influenza A, RSV, human metapneumovirus, adenovirus, and M. pneumoniae were predominantly detected during the cold season (October–March), while Rhinovirus/Enterovirus circulated throughout the year. A strong positive correlation was observed between RSV and influenza A (ρ = 0.68, p = 0.011). Sequential sample analysis suggested that many co-detections may reflect sequential rather than simultaneous infections, potentially representing residual nucleic acid from recent infections.
conclusionsReal-life BioFire RP2.1 Plus testing demonstrated high etiological diversity, frequent co-detections, and pronounced seasonal dynamics of respiratory pathogens in the post-pandemic period, confirming the clinical and epidemiological value of syndromic multiplex PCR–based respiratory diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.